Idexx Laboratories vs Medline
Idexx Laboratories (IDXX) and Medline (MDLN) side by side: how big they are, what they earn, how their shares have moved and what insiders, members of Congress and funds reported. Figures from filings and closing prices; none of this is a view on either stock.
- Market value
- $53.3B
- Last close
- $676.21
- 12 months
- −1.9%
- Market value
- $48.7B
- Last close
- $37.04
- 12 months
- —
At a glance
- The biggest part of Idexx Laboratories's revenue is CAG (92%); at Medline it is Supply Chain Solutions (52%).
- Idexx Laboratories earns 64% of its revenue in the United States, Medline 93%.
- Idexx Laboratories and Medline are close in size by market value ($53.3B and $48.7B).
- In their last fiscal years Idexx Laboratories kept 24.6% of revenue as net income and Medline 4.1%.
- In the last 90 days insiders reported 0 open-market purchases at Idexx Laboratories and 0 at Medline; members of Congress disclosed 0 trades in Idexx Laboratories and 0 in Medline.
- Next results: Idexx Laboratories Feb 1, 2027, Medline not announced.
How each one makes money: Idexx Laboratories revenue · Medline revenue
Share prices on one chart
Idexx Laboratories and Medline, and up to three more you add, drawn on the same scale so you can see which moved more.
Face to face
The figures that separate the two, drawn to the same scale. Every figure is also in the table below.
Size
Market value
Revenue, last fiscal year
Net income, last fiscal year
Every figure
| Idexx Laboratories IDXXNASDAQ · Health Care Equipment | Medline MDLNNASDAQ · Surgical & Medical Instruments & Apparatus | |
|---|---|---|
| Size and profitability | ||
| Market value | $53.3B | $48.7B |
| Revenue, last fiscal year | $4.3B | $28.4B |
| Net income, last fiscal year | $1.06B | $1.16B |
| Net marginNet income as a share of revenue | 24.6% | 4.1% |
| Free cash flow | ||
Prices are end-of-day closes, and fundamentals are the companies' last annual figures from their SEC filings: a − or + in the table is a fact of the filing or the close, not a forecast. Market value is the company-level figure at the last close. Counts are of records OQRO holds, by their date; insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned sales under a 10b5-1 plan are counted like other sales.
Compare with another company
Idexx Laboratories against
Common questions
How is Idexx Laboratories different from Medline?
Idexx Laboratories (IDXX) is in Health Care Equipment on NASDAQ, with $4.3B of revenue in its last fiscal year and a net margin of 24.6%. Medline (MDLN) is in Surgical & Medical Instruments & Apparatus on NASDAQ, with $28.4B of revenue in its last fiscal year and a net margin of 4.1%. The biggest part of Idexx Laboratories's revenue is CAG (92%); at Medline it is Supply Chain Solutions (52%). Idexx Laboratories earns 64% of its revenue in the United States, Medline 93%. The table above sets their figures side by side; it compares filings and is not a view on either stock.
How do Idexx Laboratories and Medline compare in size?
Idexx Laboratories has the larger market value: Idexx Laboratories $53.3B and Medline $48.7B, at the last close.
Whose share price rose more over the last 12 months, IDXX or MDLN?
A 12-month price change is not available for both companies.
Which has had more insider buying, Idexx Laboratories or Medline?
Since 2006, Idexx Laboratories insiders reported 24 open-market purchases against 0 for Medline. These are counts of what was filed, not a view on either stock.
Do members of Congress trade IDXX or MDLN?
In the last 12 months, members of Congress disclosed 2 trades in Idexx Laboratories (IDXX) and 0 in Medline (MDLN).
When did insiders last buy IDXX and MDLN?
See the record behind any of these
A free account opens the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.
Idexx Laboratories pageMedline pageRare insider trades this weekAll comparisons
https://oqro.io/compare/idxx-vs-mdln







